The store will not work correctly when cookies are disabled.
N-(2-(5-bromo-2-oxoindolin-3-yl)ethyl)acetamide
ID: ALA4091831
PubChem CID: 137655331
Max Phase: Preclinical
Molecular Formula: C12H13BrN2O2
Molecular Weight: 297.15
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)NCCC1C(=O)Nc2ccc(Br)cc21
Standard InChI: InChI=1S/C12H13BrN2O2/c1-7(16)14-5-4-9-10-6-8(13)2-3-11(10)15-12(9)17/h2-3,6,9H,4-5H2,1H3,(H,14,16)(H,15,17)
Standard InChI Key: HFLIJJYKVANWFW-UHFFFAOYSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
31.7838 -9.5958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9996 -8.5227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2667 -8.9189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7797 -8.2627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0037 -9.3482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8722 -6.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2856 -8.1141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4211 -6.9626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.2939 -9.7568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0715 -6.5293 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5881 -8.5227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5798 -9.3482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8238 -7.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0273 -7.4827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1198 -5.5759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0838 -8.9113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8811 -8.1128 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 5 1 0
3 1 1 0
4 3 1 0
5 1 1 0
6 10 1 0
7 2 2 0
8 6 2 0
9 5 2 0
10 13 1 0
11 12 2 0
12 9 1 0
13 14 1 0
14 4 1 0
15 6 1 0
4 2 1 0
7 11 1 0
3 16 2 0
11 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 297.15 | Molecular Weight (Monoisotopic): 296.0160 | AlogP: 2.01 | #Rotatable Bonds: 3 |
Polar Surface Area: 58.20 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.08 | CX Basic pKa: ┄ | CX LogP: 1.10 | CX LogD: 1.10 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.90 | Np Likeness Score: -0.66 |
References
1. Zaryanova EV, Lozinskaya NA, Beznos OV, Volkova MS, Chesnokova NB, Zefirov NS.. (2017) Oxindole-based intraocular pressure reducing agents., 27 (16): [PMID:28687205] [10.1016/j.bmcl.2017.06.065] |